Tommy
Level Icon

Followers 112
Posts 5,701
Boards Moderated 7
Alias Born 08/03/2000

Tommy
Level Icon

Message

Tommy My Stocks

Ticker Board News Price Change Chg% Added
PZG Paramount Gold and Silver Corp 0.4383 0.0098 2.29% 04/03/2013
My PZG Pitch: 10M oz AU - $18M cash - $0 debt
Market cap = 158,145,408 shares x $2.10 = $332M
Sleeper NPV = $695M - worth 2.09 x market cap
San Miguel NPV = $707M - 33% IRR PEA - 2X current price
Get Sleeper free - 5X current price for both
Sleeper - 6M oz AU now - potential 10 to 20M oz
XRA Exeter Resource Corporation 0 0 0.00% 08/05/2012
My XRA Pitch: 21,300.000 oz gold
48,400,000 oz silver
5,600,000,000 pd copper
Chile - expandable resource
Takeover candidate
ITH International Tower Hill Mines Ltd 0.73 0.0 0.00% 08/04/2012
My ITH Pitch: 20,000,000 oz gold
Paulson Gp involved
Leverage: 0.2 oz gold/share
1 oz gold = 100 oz Livengood gold
AK mining friendly
NG NovaGold 4.98 0.14 2.89% 07/29/2012
My NG Pitch: 16,800,000 oz gold reserves
+10,000000 oz gold resources
10 shares = 1.1 oz gold/share
8,900,000,000 pounds copper
10 shares - 220 pd copper
Risks - Infrastructure
RCPIQ Rock Creek Pharmaceuticals Inc. 0.000001 0.0 0.00% 07/25/2012
My RCPIQ Pitch: Explores and develops products and compounds, many tobacco-based or tobacco-related, that have the potential to address a range of neurological conditions, or to maintain a healthy metabolism.
NVIV InVivo Therapeutics Holdings Corp 7.65 -0.02 -0.26% 07/25/2012
My NVIV Pitch: Founded to develop and commercialize groundbreaking technologies for the treatment of spinal cord injuries (SCI).

Currently, there are no treatment options for SCI patients to successfully restore function following a spinal cord injury.
SA Seabridge Gold Inc. 14.02 0.42 3.09% 07/25/2012
My SA Pitch: 1+ ounce of gold reserves per common share outstanding

4.7 million ounces of gold at Courageous Lake and KSM project
Top 10 gold resources in world
All in Canada
GALT Galectin Therapeutics Inc. 2.12 0.09 4.43% 07/23/2012
My GALT Pitch: There is a vast unmet medical need for liver fibrosis, with the only current treatment option being liver transplantation. Preclinical results of our candidates have shown reversal of fibrosis in rodent models of disease, particularly in fatty liver disease.
* Market data is delayed 15-20 minutes.